Mirum Pharmaceuticals, Inc. (MIRM)

SEC filing

Mirum Pharmaceuticals, Inc.

MIRM · CIK 1759425

4 · Sep 15, 2026 · CHIEF FINANCIAL OFFICER BJERKHOLT ERIC sold 9,943 shares at $98.37/share ($978.1K); exercised options for 36.67K shares

CHIEF FINANCIAL OFFICER BJERKHOLT ERIC sold 9,943 shares at $98.37/share ($978.1K); exercised options for 36.67K shares

xslF345X06/form4-09152026_040901.xml

xslF345X06/form4-09152026_040901.xmlSEC.gov

Graphics and non-inline formats (not embedded below).